NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 414 filers reported holding NOVAVAX INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -66.7% | 135 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $6,000 | -33.3% | 135 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $9,000 | -52.6% | 135 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $19,000 | -29.6% | 135 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $27,000 | -3.6% | 135 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $28,000 | +16.7% | 135 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $24,000 | +60.0% | 135 | 0.0% | 0.01% | +100.0% |
| Q4 2020 | $15,000 | +15.4% | 135 | +12.5% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | +62.5% | 120 | +20.0% | 0.00% | +50.0% |
| Q2 2020 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |